Page last updated: 2024-08-24

fadrozole and Nausea

fadrozole has been researched along with Nausea in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, O; Abe, R; Asaishi, K; Enomoto, K; Kajiwara, T; Nomura, Y; Tominaga, T; Wada, T; Yoshida, M1
Abe, O; Abe, R; Aoyama, H; Asaishi, K; Enomoto, K; Kajiwara, T; Ohasi, Y; Tominaga, T; Yoshida, M1
Bonnefoi, HR; Coombes, RC; da Luz, RJ; Dowsett, M; Houston, SJ; Powles, TJ; Rubens, RD; Smith, IE; Trunet, PF1
Buzdar, A; Howell, A1

Reviews

1 review(s) available for fadrozole and Nausea

ArticleYear
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

    Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting

2001

Trials

3 trial(s) available for fadrozole and Nausea

ArticleYear
[Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4

    Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Estradiol; Fadrozole; Female; Humans; Middle Aged; Nausea; Postmenopause; Vomiting

1994
[Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4

    Topics: Administration, Oral; Adult; Aged; Anorexia; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Postmenopause

1994
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
    British journal of cancer, 1996, Volume: 73, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Confidence Intervals; Double-Blind Method; Fadrozole; Female; Flushing; Humans; Middle Aged; Nausea; Tamoxifen; Time Factors; Treatment Failure; Treatment Outcome

1996